DHR Danaher Corporation
Health Care · S&P 500
Next earnings: Wed 27 Jan 2027 · estimated
What 25 analyst firms say about Danaher Corporation: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
25 rated views · 26 analyst/firm records · 25 firms
Radar score
- S&P 500 · Top Picks · 6MBelow the Radar threshold of 8061
- S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8072
Recent analyst activity · last 90 days
Our tracked history has 26 reports on DHR from 20 analyst firms in the last 90 days (25 firms in the past year).
Comparing each firm's latest target with its previous one: 13 raised their price target, 1 left it unchanged and 1 has its first observed target in the past year.
Ratings, latest available report against the previous one: 1 upgrade and 1 downgrade.
Latest observed target change: Argus raised its target from $230.00 (set 24 Jul 2026) to $260.00 on 28 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Argus | David A Toung | Buy | 28 Oct 2026 | 260.00 USD |
| Baird | Catherine Schulte | Buy | 22 Oct 2026 | 254.00 USD |
| Barclays | Luke Sergott | Buy | 22 Oct 2026 | 260.00 USD |
| Citigroup | Joanne K Wuensch | Buy | 22 Oct 2026 | 270.00 USD |
| Citigroup | Patrick Donnelly | Buy | 22 Oct 2026 | 270.00 USD |
| Deutsche Bank | Unnamed analyst | Buy | 22 Jul 2026 | 240.00 USD |
| DZ Bank | Aristotelis Moutopoulos | Hold | 27 Oct 2026 | 240.00 USD |
| Evercore ISI | Vijay Kumar | Buy | 7 Oct 2026 | Conflicting reports · excluded |
| Goldman Sachs | Evie Koslosky | Buy | 22 Oct 2026 | 275.00 USD |
| Guggenheim | Subbu Nambi | Buy | 1 Oct 2026 | 250.00 USD |
| HSBC | Rajesh Kumar | Buy | 23 Oct 2026 | 260.00 USD |
| Jefferies | Tycho W Peterson | Buy | 22 Oct 2026 | 260.00 USD |
| JPMorgan | Casey Woodring | Buy | 22 Oct 2026 | 270.00 USD |
| KeyBanc Capital Markets | Paul Knight | Buy | 1 Jul 2026 | 310.00 USD |
| Leerink Partners | Puneet Souda | Buy | 22 Oct 2026 | 250.00 USD |
| Morgan Stanley | Kallum Titchmarsh | Buy | 12 Oct 2026 | 240.00 USD |
| Piper Sandler | David M Westenberg | Hold | 22 Oct 2026 | 200.00 USD · 11 Jun 2026 |
| RBC Capital Markets | Dan Leonard | Buy | 5 Oct 2026 | Conflicting reports · excluded |
| Redburn | Ed Ridley-Day | Hold | 14 Aug 2026 | Conflicting reports · excluded |
| Stifel | Daniel Arias | Buy | 22 Oct 2026 | 260.00 USD |
| TD Cowen | Dan Brennan | Buy | 22 Oct 2026 | 270.00 USD |
| UBS | Douglas Schenkel | Buy | 22 Oct 2026 | 260.00 USD |
| Weiss Ratings | Unnamed analyst | — | 16 Sep 2026 | — |
| Wells Fargo | Brandon Couillard | Hold | 22 Jul 2026 | 195.00 USD |
| Wolfe Research | Mike Polark | Hold | 1 Jun 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 6 May 2026 | Conflicting reports · excluded |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:23 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.